GMAB Genmab AS

USD 20.47 +0.02 ( +0.10)%
Icon

Genmab AS (GMAB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 20.47

+0.02 (+0.10)%

N/A

1.51M

USD 46.83(+128.79%)

USD 45.00 (+119.83%)

Icon

GMAB

Genmab AS (USD)
COMMON STOCK | NSD
USD 20.47
+0.02 ( +0.10)%

Genmab AS (GMAB) Stock Forecast

Show ratings and price targets of :
USD 46.83
(+128.79%)

Based on the Genmab AS stock forecast from 4 analysts, the average analyst target price for Genmab AS is USD 46.83 over the next 12 months. Genmab AS’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Genmab AS is Very Bullish, which is based on 2 positive signals and 0 negative signals. At the last closing, Genmab AS’s stock price was USD 20.47. Genmab AS’s stock price has changed by -3.35% over the past week, -10.14% over the past month and -35.12% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...